Pick any medical specialty other than your own. Who’s the most famous physician in it? You probably can’t name one.
Almost none of us will be known outside our field, and even those who achieve real professional fame are mostly forgotten within a few decades.
Fame is a poor reason to devote your life to medicine. The work itself matters more: caring for patients, discovering new knowledge, and teaching the next generation.
Studying for Rad Onc Oral Boards? Try out my app Rad Onc Oral Board Sim! It uses AI to generate unique cases and evaluates your spoken responses like a real board examiner. Let me know what you think! #RadOnc#ABR#MedEd
https://t.co/LBC0efSoz5
The University of Kansas School of Medicine Radiation Oncology Dept hosted Visiting Professor Alan Pollack, MD, PhD, Professor and Chair Emeritus, Radiation Oncology, University of Miami Miller School of Medicine.
@RonaldChenMD@_APollack@KUcancercenter@univmiami
The University of Kansas Medical Center hosted Visiting Professor Puneeth Iyengar, MD, PhD, Director of Metastatic Program and Thoracic Service Member, Memorial Sloan Kettering Cancer Center NY, NY.
@RonaldChenMD@KUcancercenter@MSKCancerCenter
📢 Newly published:
“Association of Patient Comorbidities With Treatment Regret Among Patients With Localized Prostate Cancer-Results From a Population-Based Cohort”
Key findings & takeaways 👇
https://t.co/mPbkaJBipM
Thank you @RonaldChenMD@KURadonc
Rahul Mali, MD, MPH, University of Kansas Medical Center Rad Onc Resident, presented "Long-Term Decision Regret Among Patients with Localized Prostate Cancer: Results from a Population-Based Cohort" at 2025 ASTRO Conference.
@RonaldChenMD@ASTRO_org@KUcancercenter@KURadonc
KU Radonc hosted Dr. Jerry Jaboin, MD, PhD, MBA, FACRO, Professor and Chair of Radiation Oncology at University of Oklahoma Health Science Center. Dr. Jaboin presented clinical trial information and met with faculty and medical residents.
@RonaldChenMD@KUcancercenter@KURadonc@drjcanJJ
Ronald Chen, MD, MPH, FASCO, FASTRO, Vice Chair of PCOR (Patient Centered Outcomes Research Committee), and NRG NCORP Committee congratulates the over 500 sites participating in NRG clinical trials who achieved 90% or greater compliance for Patient Reported Outcomes (PROs) assessments.
@KURadonc@KUcancercenter@RonaldChenMD@NRGonc
ASTRO President Sameer Keole, MD, FASTRO, initiates a new video series, the ASTRO President’s Corner! This week, Dr. Keole discusses the organizational structure of ASTRO, detailing the six Councils and makeup of the Board of Directors, and shares a brief history of the Society. https://t.co/8wDn4JrzQV
@SameerKeoleMD
Thank you Senator Roger Marshall (R-KS) for signing on as a co-sponsor for #ROCR. Now is a great time for ASTRO members to contact your reps to ask them to support the bill. https://t.co/HdvLHOfoSt
@RogerMarshallMD
Hot off the press. Pace-b efficacy results from @NEJM. Five fraction Sbrt shown to be non-inferior to standard fraction radiation. Huge congrats to the study team @EmmaHall71 @alison_tree @DrAndrewLoblaw and many others.
Randomized Phase II Trial of Hypofractionated IMRT with 2.5 Gy/Fxn vs. Standard-Fractionated IMRT, Concurrent with Carboplatin/paclitaxel and Followed ByConsolidation Durvalumab, for Patients with Stage III NSCLC – poster presentation by Dr. Reddy and Dr. Rahul Mali (PGY3) #KURadOnc #ASTRO24
“Association of Patient Comorbidities with Treatment Regret in Prostate Cancer: Results from a Population-Based Prospective Cohort”, poster presentation by Dr. Rahul Mali (PGY-3)
#KURadOnc#ASTRO24
Had a great time sharing the pivotal phase III results from the PARTIQoL trial at #ASTRO24! Honored to discuss the quality of life impacts of proton therapy vs. IMRT for localized #ProstateCancer. Read more here for the results 👉 https://t.co/liyH0VBkTH
#QualityOfLife